Global Advanced Research Journal of Pharmacy and Pharmacology (GARJPP)
October 2013 Vol. 2(1), pp. 002-012
Copyright © 2013 Global Advanced Research Journals



Pathophysiology of obesity: Focused, cause-driven approach to control the epidemic

Sunil Wimalawansa, MD, PhD, MBA, DSc

Cardio Metabolic Institute, 51 Veronica Avenue, Somerset, New Jersey, 08873, USA


Accepted 9 October, 2013


Obesity is a disease with serious public health and economic outcomes.  It is more than simply a thermodynamic, genetic, or a metabolic problem of handling calories; it is a behavioral disorder and an inflammatory disease leading to dysregulation of metabolism and energy balance, and impairment of the neurohormonal systems, leading to accumulation of intra-abdominal fat leading to serious complications.  Obesity rates as indicated by the increasing body mass index (BMI) or by abdominal girth are escalating in the United States and most industrialized countries. Approximately two-thirds of these patients develop complications that would cost billions of taxpayer dollars.  However, in Asians BMI is less relevant and the increasing abdominal girth is a better indicator that reflect accumulation of the visceral fat; the most detrimental for the health.  Obesity is a multi-factorial disease for which genetics, environment, behavioral, physical and other factors contribute to the development.  Those who are obese and sick and unhealthy, secondary to accumulation of excessive visceral fat are at high risk of developing complications.  At the current rates, it is predicted that obesity-associated deaths are going to surpass cardiovascular deaths within the next two decades.  For the majority of overweight and obese people, it is necessary to reduce only seven to ten percent of their body weight via calorie-reduced diet and increasing physical activity that would improve the metabolism and decrease potential complications and premature deaths.  In addition to reasonable weight reduction programs, controlling the obesity-associated complications requires coordinated, cause-driven, and complication-centric approaches.  Understanding the cause for the obesity in each patient would greatly facilitate the development of an individualized, sustainable, and successful treatment plan.  Therefore, the multi-factorial nature of engender obesity needs a focused, specific, cause-driven approaches to combat.  Considering the high cost of managing obesity, type 2 diabetes and their complications, prevention of obesity is the way forward that is based on causes and risk factors.  This is one of the most cost-effective approaches to decrease the obesity-associated complications, morbidities and premature deaths.

Keywords: metabolism, epidemic, adepokines, body mass index (BMI), cardiovascular, morbidity, overweight.

Related Articles

Alexandre Franco Miranda, Ismênia Amorim de Araújo, Helia Beatriz Nunes de Araújo, Edmur Carlos de Araújo and Ana Cristina Barreto Bezerra
Oral health promotion in Intensive Care Unit patients: management and adaptations
Glo. Adv. Res. J. Pharm. Pharmacol. November 2015 Vol: 4(11): - [Abstract] [Full Text - PDF] (352 KB)
Original Research Articles
Adegun Patrick Temi, Ajayi Oladimeji Akande, Salawu Adedayo Idris, Areo Peter Olufemi, Esho Julius Olusanmi and Dada Samuel Ayokunle
Effect of body mass index and age on international prostate symptom score: on men attending urology clinic in a tertiary institution in Nigeria
Glo. Adv. Res. J. Pharm. Pharmacol. April 2015 Vol: 4(4): - [Abstract] [Full Text - PDF] (135 KB)
Adobea Yaa Owusu, John Kwasi Anarfi and Eric Yeboah Tenkorang
Attitudes and views on same-sex sexual behavior in Ghana
Glo. Adv. Res. J. Pharm. Pharmacol. August 2013 Vol: 2(8): - [Abstract] [Full Text - PDF] (165 KB)
Arman Rostamzad
Molecular Epidemiology of Shigella sonnei Isolated from Clinical cases in Tehran using RAPD-PCR Method
Glo. Adv. Res. J. Pharm. Pharmacol. April 2015 Vol: 4(4): - [Abstract] [Full Text - PDF] (182 KB)
Debendranath Guha Mazumder, Kunal K Majumdar, Ishani Kar-Purkayastha, Aloke Ghose, Goutam Mistry, Chandan Saha, Ashoke Nandy and Arabinda Das
Ischemic heart disease in chronic arsenic exposure: A case control study in West Bengal
Glo. Adv. Res. J. Pharm. Pharmacol. February 2013 Vol: 2(2): - [Abstract] [Full Text - PDF] (168 KB)
Reem Bahmaid and Nahid El-Bakri
Ivabradine for Treatment of Stable Angina and Heart Failure
Glo. Adv. Res. J. Pharm. Pharmacol. December 2016 Vol: 5(12): - [Abstract] [Full Text - PDF] (124 KB)

Current Issue

Viewing Options

View Full Article - PDF
Download Full Article - PDF

Search for Articles

Sunil Wimalawansa on Google Scholar
Sunil Wimalawansa on Pubmed


Viewed 737
Printed 169
Downloaded 317
Powered By iPortal Works